Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v17-EN | Version v16-FR | |
---|---|---|
Language | English | French |
Date Updated | 2018-04-13 | 2018-03-29 |
Drug Identification Number | 02431130 | 02431130 |
Brand name | VINORELBINE INJECTION, USP | VINORELBINE INJECTION, USP |
Common or Proper name | 10 mg/ml Vinorelbine (as vinorelbine tartrate) | 10 mg/ml Vinorelbine (as vinorelbine tartrate) |
Company Name | GENERIC MEDICAL PARTNERS INC | GENERIC MEDICAL PARTNERS INC |
Ingredients | VINORELBINE | VINORELBINE |
Strength(s) | 10MG | 10MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 5ml in clear glass vial | 5ml in clear glass vial |
ATC code | L01CA | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | ||
Actual start date | 2017-12-06 | 2017-12-06 |
Estimated end date | 2018-04-30 | 2018-04-16 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | One each batch of 5 and 1 ml vials are still in post production quality review. The release date is now moved to April 30, 2018. | New batches are still in testing with revised release date of April 16, 2018. |
Health Canada comments |